Zhuo Lin

1.8k total citations
58 papers, 1.4k citations indexed

About

Zhuo Lin is a scholar working on Molecular Biology, Hepatology and Cancer Research. According to data from OpenAlex, Zhuo Lin has authored 58 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 23 papers in Hepatology and 21 papers in Cancer Research. Recurrent topics in Zhuo Lin's work include Liver Disease Diagnosis and Treatment (16 papers), MicroRNA in disease regulation (14 papers) and Cancer-related molecular mechanisms research (12 papers). Zhuo Lin is often cited by papers focused on Liver Disease Diagnosis and Treatment (16 papers), MicroRNA in disease regulation (14 papers) and Cancer-related molecular mechanisms research (12 papers). Zhuo Lin collaborates with scholars based in China, United States and Canada. Zhuo Lin's co-authors include Keqing Shi, Yongping Chen, Mei Song, Fujun Yu, Lanman Xu, Ming‐Hua Zheng, Da‐Zhi Chen, Feng‐Bin Lu, Jinlu Wu and En-De Hu and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Zhuo Lin

54 papers receiving 1.4k citations

Peers

Zhuo Lin
Mingyi Xu China
Christiane Koppe Germany
Nan You China
Liyong Pu China
Yuhui Zang China
Harun M. Said Germany
Qiaoling Pan China
Jiaohong Wang United States
Zuojin Liu China
Mingyi Xu China
Zhuo Lin
Citations per year, relative to Zhuo Lin Zhuo Lin (= 1×) peers Mingyi Xu

Countries citing papers authored by Zhuo Lin

Since Specialization
Citations

This map shows the geographic impact of Zhuo Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhuo Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhuo Lin more than expected).

Fields of papers citing papers by Zhuo Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhuo Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhuo Lin. The network helps show where Zhuo Lin may publish in the future.

Co-authorship network of co-authors of Zhuo Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Zhuo Lin. A scholar is included among the top collaborators of Zhuo Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhuo Lin. Zhuo Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Xiaobo, Qiuxia Wang, Denghui Wei, et al.. (2025). Lysosomal EGFR acts as a Rheb-GEF independent of its kinase activity to activate mTORC1. Cell Research. 35(7). 497–509. 3 indexed citations
2.
Li, Yeyang, Zhipeng Xu, Wenhui Shi, et al.. (2025). Branched poly(terphenyl trifluoroacetophenone piperidone) membranes with dual-proton conductor assist for enhancing fuel cell performance operation in high-temperature. Journal of Membrane Science. 727. 124127–124127. 7 indexed citations
3.
Xu, Yangwei, et al.. (2025). WTX-L/β-arrestin2/LCN2 axis controls vulnerability to ferroptosis in gastric cancer. iScience. 28(3). 111964–111964.
4.
Lin, Zhuo, et al.. (2025). Chloroquine Enhances Chemosensitivity of Breast Cancer via mTOR Inhibition. Biomedicines. 13(4). 948–948.
5.
Lin, Zhuo, Yanyan Li, Weiwei Liu, et al.. (2025). Metabolic alterations and immune heterogeneity in gastric cancer metastasis. iScience. 28(5). 112296–112296. 1 indexed citations
6.
Lin, Zhuo, Xu Qian, Yuan Zeng, et al.. (2022). Comprehensive Analysis Identified Mutation-Gene Signature Impacts the Prognosis Through Immune Function in Hepatocellular Carcinoma. Frontiers in Oncology. 12. 748557–748557. 1 indexed citations
7.
Sun, Hongwei, Shanshan Zhang, Yilin Zhou, et al.. (2021). An immunogenomic signature for molecular classification in hepatocellular carcinoma. Molecular Therapy — Nucleic Acids. 25. 105–115. 40 indexed citations
8.
Lin, Zhuo, et al.. (2021). An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma. Frontiers in Oncology. 11. 644416–644416. 77 indexed citations
9.
Cai, Chao, Da‐Zhi Chen, Tao Ying, et al.. (2021). MicroRNA-29c Acting on FOS Plays a Significant Role in Nonalcoholic Steatohepatitis Through the Interleukin-17 Signaling Pathway. Frontiers in Physiology. 12. 597449–597449. 11 indexed citations
10.
Huang, Weiguo, et al.. (2020). Development and Validation of the Trans-Omics Model for Pancreatic Adenocarcinoma. Epigenomics. 13(1). 15–30. 4 indexed citations
11.
Huang, Weiguo, et al.. (2020). Identification of a competing endogenous RNA network associated with prognosis of pancreatic adenocarcinoma. Cancer Cell International. 20(1). 231–231. 27 indexed citations
12.
13.
Chen, Da‐Zhi, Wenkai Chen, Chao Cai, et al.. (2019). Pre-activation of TLR3 enhances the therapeutic effect of BMMSCs through regulation the intestinal HIF-2α signaling pathway and balance of NKB cells in experimental alcoholic liver injury. International Immunopharmacology. 70. 477–485. 20 indexed citations
14.
Hu, En-De, Da‐Zhi Chen, Jinlu Wu, et al.. (2018). High fiber dietary and sodium butyrate attenuate experimental autoimmune hepatitis through regulation of immune regulatory cells and intestinal barrier. Cellular Immunology. 328. 24–32. 75 indexed citations
15.
16.
Chen, Si, Yi Chen, Bi Chen, et al.. (2015). Plumbagin Ameliorates CCl4-Induced Hepatic Fibrosis in Rats via the Epidermal Growth Factor Receptor Signaling Pathway. Evidence-based Complementary and Alternative Medicine. 2015. 1–12. 19 indexed citations
17.
Chen, Yi, Si Chen, Liyuan Liu, et al.. (2014). Mesenchymal stem cells ameliorate experimental autoimmune hepatitis by activation of the programmed death 1 pathway. Immunology Letters. 162(2). 222–228. 21 indexed citations
18.
Lin, Zhuo, Li Chen, Mei Song, Keqing Shi, & Kai‐Fu Tang. (2014). Association between a Polymorphism in miR-34b/c and Susceptibility to Cancer - a Meta-analysis. Asian Pacific Journal of Cancer Prevention. 15(17). 7251–7255. 8 indexed citations
19.
Yu, Fujun, Zhuo Lin, Jianjian Zheng, et al.. (2013). Suppression of collagen synthesis by Dicer gene silencing in hepatic stellate cells. Molecular Medicine Reports. 9(2). 707–714. 10 indexed citations
20.
Shi, Keqing, Zhuo Lin, Dewei Li, et al.. (2013). Meta-Analysis of the Association between a Polymorphism in MicroRNA-196a2 and Susceptibility to Colorectal Cancer. Oncology Research and Treatment. 36(10). 560–565. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mingyi Xu Breakdown of academic impact, for papers by Christiane Koppe Breakdown of academic impact, for papers by Nan You Breakdown of academic impact, for papers by Liyong Pu Breakdown of academic impact, for papers by Yuhui Zang Breakdown of academic impact, for papers by Harun M. Said Breakdown of academic impact, for papers by Qiaoling Pan Breakdown of academic impact, for papers by Jiaohong Wang Breakdown of academic impact, for papers by Zuojin Liu
Rankless by CCL
2026